Boston Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$176M Sell
2,027,905
-4,707,978
-70% -$451M 0.18% 166
2025
Q4
$647M Sell
6,735,883
-230,071
-3% -$22.3M 0.67% 37
2025
Q3
$664M Buy
6,965,954
+7,033
+0.1% +$647K 0.68% 35
2025
Q2
$607M Buy
6,958,921
+46,866
+0.7% +$3.97M 0.67% 37
2025
Q1
$619M Buy
6,912,055
+3,809,450
+123% +$341M 0.75% 33
2024
Q4
$248M Buy
3,102,605
+1,675,588
+117% +$145M 0.3% 125
2024
Q3
$128M Buy
1,427,017
+28,598
+2% +$2.41M 0.15% 194
2024
Q2
$110M Sell
1,398,419
-42,875
-3% -$3.51M 0.14% 203
2024
Q1
$126M Sell
1,441,294
-34,113
-2% -$2.91M 0.15% 197
2023
Q4
$122M Sell
1,475,407
-113,821
-7% -$8.67M 0.16% 201
2023
Q3
$124M Sell
1,589,228
-59,393
-4% -$4.97M 0.17% 174
2023
Q2
$145M Sell
1,648,621
-148,126
-8% -$12.8M 0.2% 164
2023
Q1
$145M Sell
1,796,747
-457,247
-20% -$37.3M 0.2% 153
2022
Q4
$175M Sell
2,253,994
-108,240
-5% -$8.77M 0.24% 139
2022
Q3
$191M Sell
2,362,234
-103,763
-4% -$9.32M 0.28% 121
2022
Q2
$221M Sell
2,465,997
-162,308
-6% -$16.4M 0.31% 112
2022
Q1
$292M Buy
2,628,305
+434,089
+20% +$45.9M 0.35% 99
2021
Q4
$227M Sell
2,194,216
-387,139
-15% -$44.8M 0.27% 129
2021
Q3
$324M Buy
2,581,355
+101,177
+4% +$13.1M 0.41% 81
2021
Q2
$308M Sell
2,480,178
-3,180,971
-56% -$399M 0.39% 85
2021
Q1
$669M Sell
5,661,149
-114,508
-2% -$13.4M 0.9% 17
2020
Q4
$677M Buy
5,775,657
+294,573
+5% +$32.4M 1.05% 13
2020
Q3
$570M Sell
5,481,084
-257,740
-4% -$25.9M 1.04% 13
2020
Q2
$526M Sell
5,738,824
-677,852
-11% -$65M 0.97% 19
2020
Q1
$578M Sell
6,416,676
-1,879,554
-23% -$200M 1.15% 12
2019
Q4
$941M Sell
8,296,230
-1,090,809
-12% -$120M 1.25% 9
2019
Q3
$1.02B Sell
9,387,039
-268,745
-3% -$28M 1.38% 7
2019
Q2
$941M Buy
9,655,784
+1,250,545
+15% +$114M 1.23% 10
2019
Q1
$766M Buy
8,405,239
+1,028,238
+14% +$92M 1.01% 20
2018
Q4
$671M Buy
7,377,001
+734,286
+11% +$68.6M 0.96% 23
2018
Q3
$653M Buy
6,642,715
+4,104,626
+162% +$379M 0.76% 35
2018
Q2
$217M Sell
2,538,089
-332,140
-12% -$27.7M 0.26% 123
2018
Q1
$230M Buy
2,870,229
+59,530
+2% +$4.91M 0.28% 109
2017
Q4
$227M Buy
2,810,699
+1,206,093
+75% +$96.6M 0.27% 122
2017
Q3
$125M Buy
1,604,606
+830,436
+107% +$68.9M 0.15% 165
2017
Q2
$68.7M Sell
774,170
-553,383
-42% -$46.7M 0.09% 209
2017
Q1
$107M Buy
1,327,553
+37,028
+3% +$2.89M 0.14% 178
2016
Q4
$91.9M Sell
1,290,525
-649,071
-33% -$51M 0.12% 183
2016
Q3
$168M Sell
1,939,596
-29,237
-1% -$2.55M 0.23% 139
2016
Q2
$171M Buy
1,968,833
+45,032
+2% +$3.64M 0.25% 138
2016
Q1
$144M Sell
1,923,801
-4,713,717
-71% -$355M 0.21% 143
2015
Q4
$511M Sell
6,637,518
-4,411,683
-40% -$332M 0.73% 35
2015
Q3
$740M Sell
11,049,201
-330,757
-3% -$24.4M 1.13% 15
2015
Q2
$843M Sell
11,379,958
-113,889
-1% -$8.7M 1.21% 14
2015
Q1
$896M Buy
11,493,847
+3,342,279
+41% +$253M 1.33% 10
2014
Q4
$589M Buy
8,151,568
+147,563
+2% +$10.3M 0.88% 28
2014
Q3
$496M Buy
8,004,005
+355,292
+5% +$22.6M 0.8% 30
2014
Q2
$488M Buy
7,648,713
+1,990,837
+35% +$121M 0.82% 28
2014
Q1
$348M Buy
5,657,876
+3,633,093
+179% +$212M 0.64% 45
2013
Q4
$116M Sell
2,024,783
-118,954
-6% -$6.74M 0.24% 121
2013
Q3
$114M Buy
2,143,737
+1,025,616
+92% +$55.2M 0.28% 115
2013
Q2
$57.5M Buy
+1,118,121
New +$55.3M 0.16% 140

Other funds holding MDT

Boston Partners's MDT Position: Q1 2026 in Review

Boston Partners reduced its Medtronic (MDT) stake by 70% in Q1 2026, selling an estimated $451M and leaving 2,027,905 shares worth $176M. The position accounts for 0.18% of the portfolio, ranked #166.

Boston Partners first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.02B in Q3 2019. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Boston Partners held 2,027,905 shares of Medtronic worth $176M as of Q1 2026.
  • Boston Partners sold 4,707,978 Medtronic shares in Q1 2026, an estimated $451M.
  • Medtronic made up 0.18% of Boston Partners's portfolio in Q1 2026, its #166 holding.
  • Boston Partners first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Boston Partners's Medtronic position peaked at $1.02B in Q3 2019.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.